Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatme...
Leadership
Thane Wettig
CEO & Director
David DeLucia
Senior VP & CFO
John Alden
Corporate Secretary & General Counsel
Gaia Vasiliver-Shamis
Director of IR & Communications - LifeSci Advisors
